MicroRNAs in chronic lymphocytic leukemia: From causality to associations and back

Expert Review of Hematology

Volumn 5, Issue 6, 2012, Pages 579-581

  Mraz, Marek ^a,b   Pospisilova, Sarka ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

BCR signaling; CLL; IGHV; miRNA; p53; Prognostic marker

Indexed keywords

ATM PROTEIN; BREAKPOINT CLUSTER REGION PROTEIN; MICRORNA; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 34A; PROTEIN BCL 2; PROTEIN KINASE ZAP 70; PROTEIN MCL 1; PROTEIN MYB; PROTEIN P53;

B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CELL FUNCTION; CELL SURVIVAL; CHROMOSOME 3; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; DOWN REGULATION; DRUG SENSITIVITY; DRUG TARGETING; FLUORESCENCE IN SITU HYBRIDIZATION; GAMMA RADIATION; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN LIGHT CHAIN GENE; MANTLE CELL LYMPHOMA; MOLECULAR PATHOLOGY; MULTIPLE MYELOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ADULT; CAUSALITY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICRORNAS; YOUNG ADULT;

EID: 84870915144     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/ehm.12.54     Document Type: Review

References (21)

1. Calin GA, Dumitru CD, Shimizu M et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99(24), 15524-15529 (2002).
2. Calin GA, Ferracin M, Cimmino A et al. A Micro-RNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353(17), 1793-1801 (2005).
3. Klein U, Lia M, Crespo M et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17(1), 28-40 (2010).
4. Lochmanova J, Navrkalova V, Dvorakova B et al. Micro-RNA mutational analysis in patients with chronic lymphocytic leukemia. Presented at: XIV. International Workshop on Chronic Lymphocytic Leukemia, Houston, TX, USA, 28-30 October 2011.
5. Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J. Micro-RNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk. Lymphoma 50(3), 506-509 (2009).
6. Chen L, Cui B, Chen G, Salcedo M, Croce MC, Kipps TJ. miR-155 contributed to chronic lymphocytic leukemia survival by modulation of BCR-signalling. Presented at: ASH Annual Meeting and Exposition, San Diego, CA, USA, 10-13 December 2011.
7. Li S, Moffett HF, Lu J et al. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLoS ONE 6(3), e16956 (2011).
8. Costinean S, Zanesi N, Pekarsky Y et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E (mu)- miR155 transgenic mice. Proc. Natl Acad. Sci. USA 103(18), 7024-7029 (2006).
9. Vargova K, Curik N, Burda P et al. MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood 117(14), 3816-3825 (2011).
10. Mraz M, Dolezalova D, Plevova K et al. MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood 119(9), 2110-2113 (2012).
11. Papakonstantinou N, Ntoufa S, Papadopoulos G, Hatzigeorgiou A, Anagnostopoulos A, Stamatopoulos K. Distinct profiles of miRNAs modulating immune signaling pathways in different subsets of chronic lymphocytic leukemia. Presented at: EHA Annual Meeting, Amsterdam, The Netherlands, 14-17 June 2012.
12. Mraz M, Malinova K, Kotaskova J et al. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia 23(6), 1159-1163 (2009).
13. Zenz T, Mohr J, Eldering E et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 113(16), 3801-3808 (2009).
14. Asslaber D, Piñón JD, Seyfried I et al. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 115(21), 4191-4197 (2010).
15. He L, He X, Lim LP et al. A microRNA component of the p53 tumour suppressor network. Nature 447(7148), 1130-1134 (2007).
16. Mraz M, Cerna K, Mayerova V et al. MicroRNA-34a as a marker for fludarabine resistance and impairment of p53-pathway in chronic lymphocytic leukemia. Presented at: ASH Annual Meeting, Atlanta, GA, USA, 8-11 December 2012.
17. Fabbri M, Bottoni A, Shimizu M et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 305(1), 59-67 (2011).
18. Pallasch CP, Patz M, Park YJ et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 114(15), 3255-3264 (2009).
19. Sampath D, Calin GA, Puduvalli VK et al. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood 113(16), 3744-3753 (2009).
20. Baer C, Claus R, Frenzel LP et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res. 72(15), 3775-3785 (2012).
21. Zhang Y, Roccaro AM, Rombaoa C et al. LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas. Blood 120(8), 1678-1686 (2012).